19 October 2026

strategyland.uk

RTW Biotech Opportunities Ltd (RTW)

Rank #5 of 280 - Financials - UK Equities

Home/Stocks/Financials

RTW Biotech Opportunities Ltd

RTW.L·Financials·Market Cap £713m

Rank #5 of 280

Quantitative Model · 280 Stocks Analysed

£2.22

+2.78% YTD

52W: £1.58 - £2.64

Factor Analysis Summary

Editorial assessment generated from RTW Biotech Opportunities Ltd's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, RTW Biotech Opportunities Ltd (RTW.L) currently holds an overall rank of #5 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include valuation (P/E 1.6), where it demonstrates compelling valuation metrics, trading at a discount to peer averages on key multiples; profitability (ROE 32.7%, net margin 95.3%), where it demonstrates strong profitability metrics, ranking in the top quartile for earnings quality and return on capital; and market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation.

Areas requiring attention include technical (RSI 27.8), where bearish technical positioning with price trading below key trend indicators, as well as solvency (debt/equity 0.2), where balance sheet metrics are unexceptional and offer limited downside protection.

Within the Financials sector, RTW Biotech Opportunities Ltd sits at composite rank #5, outperforming the Financials peer average (rank 10). Among 7 Financials names in our coverage, it ranks above 5 peers and below 1.

With a composite rank in the top decile (better than 99% of the universe) and 3 factors in the top quartile, RTW Biotech Opportunities Ltd presents a broadly attractive multi-factor profile, led by valuation and tempered only by technical.

Strongest Factors

Valuation — Rank 7/280 (top quartile)
Profitability — Rank 9/280 (top quartile)
Market Trading — Rank 69/280 (top quartile)

Weakest Factors

Technical — Rank 229/280 (below average)
Solvency — Rank 145/280 (middle of the pack)

Score Analysis

RTW Biotech Opportunities Ltd is ranked #5 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

94/280

Average Score

Liquidity

Fair116/280

Valuation

Excellent7/280

Profitability

Excellent9/280

Solvency

Fair145/280

Asset Efficiency

Good81/280

Mkt Trading

Excellent69/280

Technical

Weak229/280

1. Liquidity

Score: 116/280

How liquid is RTW and can it meet its short-term obligations?

0/6

liquidity criteria met

Metric

Sector Range

Value

Rank

–

Quick Ratio

N/A

Range: N/A

–

Current Ratio

N/A

Range: N/A

–

TTM Operating Cash Flow

N/A

Range: N/A

–

Liquidity Coverage Ratio

100-150

N/A

Range: 100-150

–

Intangible Asset Ratio

10 - 30

N/ARank 193/280

Range: 10 - 30Rank 193/280

–

Cash-to-Debt Ratio

N/A

0.04xRank 235/280

Range: N/ARank 235/280

Key Liquidity Metrics

Quick Ratio

N/A

Sector: N/A

Current Ratio

N/A

Sector: N/A

Overall Liquidity Rank

Rank within universe#116/280

Best (1)Worst (280)

2. Valuation

Score: 7/280

Is RTW undervalued compared to its peers and fair value metrics?

2/7

valuation criteria met

Metric

Sector Range

Value

Rank

–

FY27e P/E

8x - 18x

N/A

Range: 8x - 18x

–

FY26e P/E

8x - 18x

N/A

Range: 8x - 18x

–

FY27e Net Div Yld (%)

3.0 - 8.0

N/A

Range: 3.0 - 8.0

–

Div Payout Ratio

30 - 55

N/ARank 50/280

Range: 30 - 55Rank 50/280

–

Current EV/EBITDA

N/A

3.5xRank 26/280

Range: N/ARank 26/280

✓

Current P/TBV

0.8x - 2.0x

0.81xRank 30/280

Range: 0.8x - 2.0xRank 30/280

✓

Current P/B

0.8x - 2.0x

0.81xRank 35/280

Range: 0.8x - 2.0xRank 35/280

Key Valuation Metrics

TTM P/E

Price-to-Earnings

1.6x

FY26e P/E

Forward estimate

N/A

FY27e P/E

Forward estimate

N/A

Current P/B

Price-to-Book

0.81x

Current P/TBV

Tangible Book Value

0.81x

Current EV/EBITDA

Enterprise Value

3.5x

FY26e EV/EBITDA

Forward estimate

N/A

FY27e EV/EBITDA

Forward estimate

N/A

Dividend

RTW does not currently pay a significant dividend.

—

No dividend data available for this stock.

3. Profitability

Score: 9/280

How profitable is RTW relative to its peers?

0/7

profitability criteria met

Metric

Sector Range

Value

Rank

✗

TTM Profit Margin

15 - 30

95.3%Rank 26/280

Range: 15 - 30Rank 26/280

–

T12 FCF Margin

N/A

Range: N/A

–

FY27e RoE

10 - 16

N/A

Range: 10 - 16

–

FY26 EPS Growth

8 - 15

N/A

Range: 8 - 15

–

FY27e EPS Growth

6 - 12

N/A

Range: 6 - 12

–

NIM

1.5 - 3.2

N/A

Range: 1.5 - 3.2

–

Expense Ratio

50 - 65

N/A

Range: 50 - 65

TTM Profit Margin

95.3%

Current RoCE

32.7%

FY27e RoE

N/A

T12 FCF Margin

N/A

4. Solvency

Score: 145/280

How strong is RTW's balance sheet and financial position?

0/6

solvency criteria met

Metric

Sector Range

Value

Rank

✗

Debt/Eqt

0.5x - 1.5x

0.19xRank 94/280

Range: 0.5x - 1.5xRank 94/280

–

Interest Coverage Ratio

N/A

Range: N/A

–

Net Leverage Ratio

N/A

Range: N/A

–

Altman Z-Score (Manufacturing)

N/A

N/ARank 240/280

Range: N/ARank 240/280

–

Z-Score (Non Manufacturing)

N/A

Rank 246Rank 246/280

Range: N/ARank 246/280

–

CapAdeq Ratio Tier1

13 - 18

N/A

Range: 13 - 18

Key Solvency Metrics

Debt/Eqt

0.19x

Net Leverage Ratio

N/A

Interest Coverage

N/A

T12 FCF Margin

N/A

Altman Z-Score

N/A

Distress Zone

01.812.995+

5. Asset Efficiency

Score: 81/280

How efficiently does RTW deploy its assets and intellectual capital?

0/5

asset efficiency criteria met

Metric

Sector Range

Value

Rank

–

Efficiency Ratio

50 - 70

N/A

Range: 50 - 70

–

TTM Asset Turnover Ratio

N/A

0.46xRank 136/280

Range: N/ARank 136/280

–

TTM CAPEX/Sales

1 - 3

N/A

Range: 1 - 3

–

Working Capital Turnover

N/A

Range: N/A

–

R&D/Sales FY27e

N/A

Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#81/280

Best (1)Worst (280)

6. Market Trading

Score: 69/280

How liquid and actively traded is RTW?

1/2

market trading criteria met

Metric

Sector Range

Value

Rank

–

Intraday Sentiment (%)

40 - 75

N/A

Range: 40 - 75

–

10D-Avg v/s 3M-Avg Vol

N/A

145%Rank 50/280

Range: N/ARank 50/280

✓

Avg Directional Index 30D

012 - 45

33.9Rank 15/280

Range: 012 - 45Rank 15/280

–

Parabolic SAR

N/A

2.19Rank 277/280

Range: N/ARank 277/280

–

Stock Rating Rank

N/A

Range: N/A

Market Cap

£712,933,127

Enterprise Value

£919,485,685

Trading Volume

7. Technical

Score: 229/280

What do the technical indicators say about RTW?

0/5

technical criteria met

Metric

Chart

Sector Range

Value

Rank

–

CMP v/s 52-WH

2.641.58

-15.9%CMP: 2.22

N/A

-15.9%Rank 178/280

2.641.58

-15.9%CMP: 2.22

Range: N/ARank 178/280

–

CMP v/s 52-WL

2.641.58

+40.5%CMP: 2.22

N/A

40.5%Rank 198/280

2.641.58

+40.5%CMP: 2.22

Range: N/ARank 198/280

–

RSI 14D

027.8 - Oversold100

N/A

27.8Rank 100/280

027.8 - Oversold100

Range: N/ARank 100/280

–

MA50 - MA200

2.25+0.192.43

N/A

BullishRank 199/280

2.25+0.192.43

Range: N/ARank 199/280

–

MACD Rank

Golden Cross

MACD: -0.01

N/A

-0.01

Golden Cross

MACD: -0.01

Range: N/A

RSI (14 Day)

27.8

Oversold

0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA2.43

200 SMA2.25

SignalGolden Cross (Bullish)

MACD-0.01

Risk Metrics

Beta

N/A

3-Yr Std Dev

N/A

5-Yr Std Dev

N/A

Peer Comparison

How does RTW compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
RTW	#5	116	7	9	145	69	229
MUT.L	#3	128	38	24	56	27	8
BPCR.L	#7	163	34	56	9	112	76
RCP.L	#9	179	26	22	59	13	2
AGT.L	#11	108	57	55	72	90	79
TBCG.L	#14	29	55	38	257	129	18
MNTN.L	#15	221	44	74	3	203	262

Similar Stocks

Other top-ranked stocks in the Financials sector

View all

MUT.L

Murray Income Trust PLC

RIT Capital Partners PLC

Schiehallion Fund Ltd

Rank #15Score: 135

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

Methodology Note

The analysis presented for RTW Biotech Opportunities Ltd is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Strategyland Research Center - strategyland.ukThis report is for informational purposes only. Not financial advice.